This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Vicente W. Kwan, MD
Missouri State Sanatorium Mt. Vernon

JAMA. 1970;211(9):1544.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

The increasing use of pentazocine (Talwin) as an analgesic has led to many reports of dependence as well as abuse of the drug. Its use in pregnancy like most drugs is not recommended although no teratogenic or embryotoxic effects have been observed in reproductive studies in animals. This patient had a relatively prolonged administration of pentazocine during pregnancy.

Report of a Case.—

The patient is a 23-year-old white female whose last menstrual period was Nov 5, 1968. The first two months of pregnancy were uneventful. The third month was characterized by frequent and severe low pelvic cramps and occasional spotting. The pains were controlled by the intramuscular administration of 45 to 60 mg of pentazocine every four to six hours. This was continued for approximately one month. During the fourth month of pregnancy the patient received lututrin (Lutrexin) in dosage ranging from 8 to 12 tablets a . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?